AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 9635312 — intervention group
Group type: EXPERIMENTAL
Intervention: Unfilled sealant
Number of subjects: 72
Study 9635312 — intervention group
Group type: COMPARATOR
Intervention: Filled sealant
Number of subjects: 72
Study 7842343 — intervention group
Group type: EXPERIMENTAL
Intervention: Ginsenoside in total added into the cardioplegic solution
Number of subjects: 30
Study 7842343 — intervention group
Group type: EXPERIMENTAL
Intervention: Ginsenoside Rb added instead of Ginsenoside in total
Number of subjects: 30
Study 7842343 — intervention group
Group type: COMPARATOR
Intervention: No Ginsenoside used (Control group)
Number of subjects: 30
Study 3123539 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral cromolyn sodium (up to 40 mg/kg/day for 1 week)
Number of subjects: 10
Study 3123539 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study 31264770 — intervention group
Group type: EXPERIMENTAL
Intervention: Unilateral strength training with mirror therapy (MST)
Number of subjects: 31
Study 31264770 — intervention group
Group type: COMPARATOR
Intervention: Unilateral strength training (ST)
Number of subjects: 31
Study 27914243 — intervention group
Group type: EXPERIMENTAL
Intervention: Bevacizumab-containing neoadjuvant therapy (BCP)
Number of subjects: 95
Study 27914243 — intervention group
Group type: COMPARATOR
Intervention: Carboplatin-paclitaxel (CP)
Number of subjects: 95
Study 25892379 — intervention group
Group type: EXPERIMENTAL
Intervention: Sen Sib (SS) massage
Number of subjects: 30
Study 25892379 — intervention group
Group type: EXPERIMENTAL
Intervention: Ratchsamnak (RS) massage
Number of subjects: 30
Study 25892379 — intervention group
Group type: EXPERIMENTAL
Intervention: Chaloeysak (CS) massage
Number of subjects: 30
Study 25892379 — intervention group
Group type: COMPARATOR
Intervention: Control group (no massage)
Number of subjects: 30
Study 24013512 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 × 5 Gy irradiation followed by oxaliplatin-based chemotherapy
Number of subjects: 40
Study 20861405 — intervention group
Group type: EXPERIMENTAL
Intervention: 250 units of vitamin D3 per day
Number of subjects: 40
Study 20861405 — intervention group
Group type: EXPERIMENTAL
Intervention: 500 units of vitamin D3 per day
Number of subjects: 40
Study 20861405 — intervention group
Group type: COMPARATOR
Intervention: Control group (not explicitly defined, but implied as no supplementation)
Number of subjects: 40
Study 20861405 — intervention group
Group type: EXPERIMENTAL
Intervention: Sun exposure
Number of subjects: 40
Study 20861405 — intervention group
Group type: EXPERIMENTAL
Intervention: UVB exposure
Number of subjects: 40
Study 19663688 — intervention group
Group type: EXPERIMENTAL
Intervention: DPSGC formulation A (25 mg)
Number of subjects: 24
Study 19663688 — intervention group
Group type: EXPERIMENTAL
Intervention: DPSGC formulation B (25 mg)
Number of subjects: 24
Study 19663688 — intervention group
Group type: EXPERIMENTAL
Intervention: Liquid diclofenac formulation (1 mL, 25 mg)
Number of subjects: 24
Study 17942039 — intervention group
Group type: EXPERIMENTAL
Intervention: Tonsilloplasty
Number of subjects: 30
Study 17942039 — intervention group
Group type: COMPARATOR
Intervention: Tonsillectomy
Number of subjects: 30
Study 15896757 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluad (containing the MF59 adjuvant)
Number of subjects: 58
Study 15896757 — intervention group
Group type: EXPERIMENTAL
Intervention: Agrippal (no adjuvant added)
Number of subjects: 58
Study 15896757 — intervention group
Group type: COMPARATOR
Intervention: Control group (not vaccinated)
Number of subjects: 58
Study 15896757 — intervention group
Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 58
Study 11889461 — intervention group
Group type: EXPERIMENTAL
Intervention: Omeprazole 20 mg, Tetracycline 500 mg, Furazolidone 200 mg (OTF group)
Number of subjects: 111
Study 9640567 — intervention group
Group type: EXPERIMENTAL
Intervention: PSX group (n=23)
Number of subjects: 46
Study 9640567 — intervention group
Group type: COMPARATOR
Intervention: Control group (n=23)
Number of subjects: 46
Study 8135389 — intervention group
Group type: COMPARATOR
Intervention: Naloxone (5 micrograms/kg)
Number of subjects: 10
Study 8135389 — intervention group
Group type: EXPERIMENTAL
Intervention: Methylnaltrexone (0.3 mg/kg)
Number of subjects: 10
Study 8135389 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study 2642790 — intervention group
Group type: EXPERIMENTAL
Intervention: Systemic antibiotic treatment combined with topical application of antibiotics in the wound at the time of wound closure
Number of subjects: 190
Study 2642790 — intervention group
Group type: COMPARATOR
Intervention: Systemic antibiotic treatment alone
Number of subjects: 190
Study 50611 — intervention group
Group type: EXPERIMENTAL
Intervention: SCHEDULE B: 2 sessions per day totalling 3,440 rads in 10‐11 days
Number of subjects: 0
Study 50611 — intervention group
Group type: EXPERIMENTAL
Intervention: SCHEDULE C: 2 sessions per day totalling 3,568 rads in 10‐11 days
Number of subjects: 0
Study 50611 — intervention group
Group type: COMPARATOR
Intervention: SCHEDULE A (control): conventional one treatment per day regimen totalling 3,760 rads in 22‐23 days
Number of subjects: 0
Study 28624990 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutrition education workshops (six sessions)
Number of subjects: 59
Study 28624990 — intervention group
Group type: COMPARATOR
Intervention: Brochures (control group)
Number of subjects: 59
Study 27913971 — intervention group
Group type: EXPERIMENTAL
Intervention: Myofunctional therapy
Number of subjects: 100
Study 27913971 — intervention group
Group type: EXPERIMENTAL
Intervention: CPAP
Number of subjects: 100
Study 27913971 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined myofunctional therapy with CPAP
Number of subjects: 100
Study 27913971 — intervention group
Group type: COMPARATOR
Intervention: Placebo myofunctional therapy
Number of subjects: 100
Study 26849547 — intervention group
Group type: EXPERIMENTAL
Intervention: Greek folk dancing (experimental group)
Number of subjects: 63
Study 26849547 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 63
Study 23061531 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous bolus injection of 2.5 mg/kg of Cyclosporine-A (CsA) before TLT
Number of subjects: 101
Study 23061531 — intervention group
Group type: COMPARATOR
Intervention: Normal saline (control)
Number of subjects: 101
Study 21198740 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic exercise training during pregnancy
Number of subjects: 84
Study 21198740 — intervention group
Group type: COMPARATOR
Intervention: Control group (nontraining participants)
Number of subjects: 84
Study 17611167 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group (Safer Choices 2 program)
Number of subjects: 711
Study 17611167 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 711
Study 16604967 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 ml of saline solution with 100 ml of contrast material (300 mgI/ml)
Number of subjects: 120
Study 16604967 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 ml of saline solution with 100 ml of contrast material (350 mgI/ml)
Number of subjects: 120
Study 16604967 — intervention group
Group type: COMPARATOR
Intervention: 100 ml of contrast material (300 mgI/ml) only
Number of subjects: 120
Study 16604967 — intervention group
Group type: COMPARATOR
Intervention: 100 ml of contrast material (350 mgI/ml) only
Number of subjects: 120
Study 12611440 — intervention group
Group type: EXPERIMENTAL
Intervention: Active elbow flexion and extension
Number of subjects: 20
Study 12611440 — intervention group
Group type: EXPERIMENTAL
Intervention: Active elbow flexion
Number of subjects: 20
Study 12611440 — intervention group
Group type: EXPERIMENTAL
Intervention: Prolonged elbow extension (unweighted)
Number of subjects: 20
Study 12611440 — intervention group
Group type: EXPERIMENTAL
Intervention: Prolonged elbow extension (weighted)
Number of subjects: 20
Study 12611440 — intervention group
Group type: EXPERIMENTAL
Intervention: Across time
Number of subjects: 20
Study 9873961 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol‐Propofol (P‐P)
Number of subjects: 100
Study 9873961 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol‐Isoflurane (P‐I)
Number of subjects: 100
Study 9873961 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol‐Desflurane (P‐D)
Number of subjects: 100
Study 9873961 — intervention group
Group type: COMPARATOR
Intervention: Spinal anesthesia (S)
Number of subjects: 100
Study 12836710 — intervention group
Group type: EXPERIMENTAL
Intervention: Lisinopril 10 mg once daily
Number of subjects: 30
Study 12836710 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study 2116533 — intervention group
Group type: EXPERIMENTAL
Intervention: Peptide-based enteral diet (Reabilan HN)
Number of subjects: 18
Study 2116533 — intervention group
Group type: COMPARATOR
Intervention: Intact-protein enteral diet (Osmolite HN)
Number of subjects: 18
Study 356593 — intervention group
Group type: EXPERIMENTAL
Intervention: 6-methylprednisolone
Number of subjects: 27
Study 356593 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 27
Study 356593 — intervention group
Group type: EXPERIMENTAL
Intervention: Liver biopsy feasibility
Number of subjects: 27
Study 30579500 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention for reducing cholesterol and cardiovascular risk
Number of subjects: 0
Study 30579500 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study 27036712 — intervention group
Group type: EXPERIMENTAL
Intervention: Weight training followed by speed training (weights speed)
Number of subjects: 15
Study 27036712 — intervention group
Group type: EXPERIMENTAL
Intervention: Speed training followed by weight training (speed weights)
Number of subjects: 15
Study 27036712 — intervention group
Group type: EXPERIMENTAL
Intervention: Speed training sessions
Number of subjects: 15
Study 27036712 — intervention group
Group type: COMPARATOR
Intervention: Weight training sessions
Number of subjects: 15
Study 25150116 — intervention group
Group type: EXPERIMENTAL
Intervention: Blueberry powder (BB), equivalent to 250 g berries daily for 6 weeks
Number of subjects: 25
Study 22672772 — intervention group
Group type: EXPERIMENTAL
Intervention: Extracorporeal shock wave therapy (ESWT)
Number of subjects: 20
Study 22672772 — intervention group
Group type: COMPARATOR
Intervention: Placebo (sham treatment)
Number of subjects: 20
Study 19470551 — intervention group
Group type: EXPERIMENTAL
Intervention: Real electro‐acupuncture (n = 30)
Number of subjects: 60
Study 19470551 — intervention group
Group type: COMPARATOR
Intervention: Sham electro‐acupuncture (n = 30)
Number of subjects: 60
Study 17305635 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical cyclosporin
Number of subjects: 13
Study 17305635 — intervention group
Group type: COMPARATOR
Intervention: Triamcinolone acetonide 0.1%
Number of subjects: 13
Study 15352148 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinical pathway (CP) for dementia treatment
Number of subjects: 43
Study 15352148 — intervention group
Group type: COMPARATOR
Intervention: Conventional medical practice (Control)
Number of subjects: 43
Study 12402726 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient-controlled epidural analgesia (PCEA)
Number of subjects: 640
Study 12402726 — intervention group
Group type: COMPARATOR
Intervention: Continuous epidural infusion (CEI)
Number of subjects: 640
Study 9809932 — intervention group
Group type: EXPERIMENTAL
Intervention: Simvastatin (20 mg daily)
Number of subjects: 16
Study 9809932 — intervention group
Group type: EXPERIMENTAL
Intervention: Hormone Replacement Therapy (HRT) (0.625 mg of conjugated estrogen and 2.5 mg of medroxyprogesterone acetate daily)
Number of subjects: 16
Study 9809932 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of HRT and Simvastatin
Number of subjects: 16
Study 9809932 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study 8689742 — intervention group
Group type: EXPERIMENTAL
Intervention: Open flap/expanded polytetrafluoroethylene (e‐PTFE) membrane combination therapy
Number of subjects: 0
Study 8689742 — intervention group
Group type: COMPARATOR
Intervention: Open flap therapy alone
Number of subjects: 0
Study 2667523 — intervention group
Group type: EXPERIMENTAL
Intervention: Nisoldipine
Number of subjects: 0
Study 2667523 — intervention group
Group type: EXPERIMENTAL
Intervention: Atenolol
Number of subjects: 0
Study 2667523 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 0
Study 656253 — intervention group
Group type: EXPERIMENTAL
Intervention: Enflurane 1%
Number of subjects: 20
Study 656253 — intervention group
Group type: COMPARATOR
Intervention: Halothane 0.5%
Number of subjects: 20
Study 31184539 — intervention group
Group type: EXPERIMENTAL
Intervention: Countermovement Jump (CMJ) with 10% body weight load
Number of subjects: 40
Study 31184539 — intervention group
Group type: EXPERIMENTAL
Intervention: Squat Jump (SJ) with 10% body weight load
Number of subjects: 40
Study 31184539 — intervention group
Group type: COMPARATOR
Intervention: Countermovement Jump (CMJ) without additional load
Number of subjects: 40
Study 31184539 — intervention group
Group type: COMPARATOR
Intervention: Squat Jump (SJ) without additional load
Number of subjects: 40
Study 31184539 — intervention group
Group type: EXPERIMENTAL
Intervention: Unilateral jumps on each leg with and without an added load
Number of subjects: 40
Study 28336297 — intervention group
Group type: EXPERIMENTAL
Intervention: Home-based telerehabilitation program (12-week, real-time exercise and education intervention delivered twice weekly via online videoconferencing)
Number of subjects: 53
Study 28336297 — intervention group
Group type: COMPARATOR
Intervention: Traditional hospital outpatient-based program (12-week, same duration and frequency as telerehabilitation)
Number of subjects: 53
Study 28336297 — intervention group
Group type: EXPERIMENTAL
Intervention: Home-based telerehabilitation program
Number of subjects: 53
Study 28336297 — intervention group
Group type: COMPARATOR
Intervention: Traditional hospital outpatient-based program
Number of subjects: 53
Study 25812548 — intervention group
Group type: EXPERIMENTAL
Intervention: Craniocervical flexion (CCF) exercises
Number of subjects: 60
Study 25812548 — intervention group
Group type: EXPERIMENTAL
Intervention: Cervical flexion (CF) exercises
Number of subjects: 60
Study 24365174 — intervention group
Group type: EXPERIMENTAL
Intervention: Motivational, individual, and locally anchored exercise intervention (four motivational interviews, six months membership to a sport club, global positioning watch)
Number of subjects: 236
Study 24365174 — intervention group
Group type: COMPARATOR
Intervention: Standard care (one hour motivational interview, follow-up interview if requested)
Number of subjects: 236
Study 21367826 — intervention group
Group type: EXPERIMENTAL
Intervention: 3M Unitek, 0·014 inch Nitinol, 0·017 inch × 0·017 inch heat activated Ni‐Ti
Number of subjects: 132
Study 21367826 — intervention group
Group type: COMPARATOR
Intervention: GAC international, 0·014 inch Sentalloy, 0·016 × 0·022 inch Bioforce
Number of subjects: 132
Study 21367826 — intervention group
Group type: COMPARATOR
Intervention: Ormco corporation, 0·014 inch Damon Copper Ni‐Ti, 0·014 × 0·025 inch Damon Copper Ni‐Ti
Number of subjects: 132
Study 19284553 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of 0.5 mEq/Kg magnesium and 2 mg/Kg vitamin B6
Number of subjects: 0
Study 19284553 — intervention group
Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 0
Study 17313494 — intervention group
Group type: COMPARATOR
Intervention: Intravenous theophylline
Number of subjects: 40
Study 17313494 — intervention group
Group type: COMPARATOR
Intervention: Oral theophylline
Number of subjects: 40
Study 16936810 — intervention group
Group type: EXPERIMENTAL
Intervention: 30% iron-saturated bovine lactoferrin (bLf) (100 mg twice a day)
Number of subjects: 300
Study 16936810 — intervention group
Group type: EXPERIMENTAL
Intervention: Ferrous sulfate (520 mg once a day)
Number of subjects: 300
Study 16936810 — intervention group
Group type: COMPARATOR
Intervention: Control group (pregnant women refusing treatment)
Number of subjects: 300
Study 14503831 — intervention group
Group type: EXPERIMENTAL
Intervention: RTD fiber posts removal kit (subgroup A)
Number of subjects: 60
Study 14503831 — intervention group
Group type: EXPERIMENTAL
Intervention: Diamond bur and Largo bur (subgroup B)
Number of subjects: 60
Study 10559098 — intervention group
Group type: EXPERIMENTAL
Intervention: AECC radiographic criterion for ALI-ARDS
Number of subjects: 21
Study 9122016 — intervention group
Group type: EXPERIMENTAL
Intervention: Dipyridamole echocardiography test
Number of subjects: 97
Study 1934867 — intervention group
Group type: EXPERIMENTAL
Intervention: Fish oil (5 gm omega-3 fatty acids per day for 30 days)
Number of subjects: 26
Study 1934867 — intervention group
Group type: EXPERIMENTAL
Intervention: Naloxone (10 mg intravenous before the cold pressor test)
Number of subjects: 26
Study 1934867 — intervention group
Group type: COMPARATOR
Intervention: Placebo (for both fish oil and naloxone)
Number of subjects: 26
Study 7011222 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefoxitin +/‐ amikacin
Number of subjects: 100
Study 7011222 — intervention group
Group type: COMPARATOR
Intervention: Clindamycin + amikacin
Number of subjects: 100
Study 31055725 — intervention group
Group type: EXPERIMENTAL
Intervention: Skin staples (29 patients)
Number of subjects: 61
Study 31055725 — intervention group
Group type: COMPARATOR
Intervention: Nylon sutures (32 patients)
Number of subjects: 61
Study 31055725 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 61
Study 31161217 — intervention group
Group type: EXPERIMENTAL
Intervention: Red meat diet
Number of subjects: 113
Study 31161217 — intervention group
Group type: EXPERIMENTAL
Intervention: White meat diet
Number of subjects: 113
Study 31161217 — intervention group
Group type: COMPARATOR
Intervention: Nonmeat protein diet
Number of subjects: 113
Study 31161217 — intervention group
Group type: EXPERIMENTAL
Intervention: High saturated fat intake
Number of subjects: 113
Study 31161217 — intervention group
Group type: COMPARATOR
Intervention: Low saturated fat intake
Number of subjects: 113
Study 27990661 — intervention group
Group type: EXPERIMENTAL
Intervention: Increasing BMI
Number of subjects: 7275
Study 27990661 — intervention group
Group type: EXPERIMENTAL
Intervention: Decreased androgen levels
Number of subjects: 7275
Study 25686538 — intervention group
Group type: EXPERIMENTAL
Intervention: Online pain self-management program
Number of subjects: 228
Study 25686538 — intervention group
Group type: COMPARATOR
Intervention: Wait-list control condition
Number of subjects: 228
Study 23977198 — intervention group
Group type: EXPERIMENTAL
Intervention: DEP-CAF (5 mg.kg(‐1) of caffeine intake 1 hour before the trial)
Number of subjects: 7
Study 23977198 — intervention group
Group type: COMPARATOR
Intervention: DEP-PLA (placebo after CHO availability-lowering exercise)
Number of subjects: 7
Study 23977198 — intervention group
Group type: COMPARATOR
Intervention: CON (no previous exercise)
Number of subjects: 7
Study 23977198 — intervention group
Group type: EXPERIMENTAL
Intervention: DEP-CAF
Number of subjects: 7
Study 23977198 — intervention group
Group type: COMPARATOR
Intervention: DEP-PLA and CON
Number of subjects: 7
Study 21410130 — intervention group
Group type: EXPERIMENTAL
Intervention: Electric muscle stimulation and standard physiotherapy for 6 weeks
Number of subjects: 70
Study 21410130 — intervention group
Group type: COMPARATOR
Intervention: Physiotherapy only
Number of subjects: 70
Study 19752272 — intervention group
Group type: EXPERIMENTAL
Intervention: Cephalothin in severely burned patients
Number of subjects: 14
Study 19752272 — intervention group
Group type: COMPARATOR
Intervention: Healthy volunteers (control group)
Number of subjects: 14
Study 17254579 — intervention group
Group type: EXPERIMENTAL
Intervention: Gonadotropin in combination with metformin
Number of subjects: 0
Study 17254579 — intervention group
Group type: COMPARATOR
Intervention: Metformin
Number of subjects: 0
Study 15491275 — intervention group
Group type: EXPERIMENTAL
Intervention: Angry opponent
Number of subjects: 3
Study 15491275 — intervention group
Group type: EXPERIMENTAL
Intervention: Happy opponent
Number of subjects: 3
Study 15491275 — intervention group
Group type: COMPARATOR
Intervention: No emotion (control)
Number of subjects: 3
Study 15491275 — intervention group
Group type: EXPERIMENTAL
Intervention: Low time pressure
Number of subjects: 3
Study 15491275 — intervention group
Group type: EXPERIMENTAL
Intervention: High time pressure
Number of subjects: 3
Study 15491275 — intervention group
Group type: EXPERIMENTAL
Intervention: Low power
Number of subjects: 3
Study 15491275 — intervention group
Group type: EXPERIMENTAL
Intervention: High power
Number of subjects: 3
Study 11585696 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral formulation with external preparation
Number of subjects: 53
Study 11585696 — intervention group
Group type: COMPARATOR
Intervention: Oral formulation alone
Number of subjects: 53
Study 9141729 — intervention group
Group type: EXPERIMENTAL
Intervention: Group exercise program (12 months)
Number of subjects: 187
Study 9141729 — intervention group
Group type: COMPARATOR
Intervention: Control group (no exercise)
Number of subjects: 187
Study 7957534 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrocortisone (HC) 100 mg
Number of subjects: 18
Study 7957534 — intervention group
Group type: COMPARATOR
Intervention: Methylprednisolone (MP) 20 mg
Number of subjects: 18
Study 7957534 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrocortisone (HC) 200 mg
Number of subjects: 18
Study 7957534 — intervention group
Group type: COMPARATOR
Intervention: Methylprednisolone (MP) 40 mg
Number of subjects: 18
Study 7957534 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrocortisone (HC) 400 mg
Number of subjects: 18
Study 7957534 — intervention group
Group type: COMPARATOR
Intervention: Methylprednisolone (MP) 80 mg
Number of subjects: 18
Study 3608594 — intervention group
Group type: EXPERIMENTAL
Intervention: Pen method of measuring skin induration
Number of subjects: 135
Study 3608594 — intervention group
Group type: COMPARATOR
Intervention: Palpation method of measuring skin induration
Number of subjects: 135
Study 31005823 — intervention group
Group type: EXPERIMENTAL
Intervention: 24-epibrassinolide (10-8 M)
Number of subjects: 0
Study 31005823 — intervention group
Group type: COMPARATOR
Intervention: Control (no treatment)
Number of subjects: 0
Study 28099755 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin analogue (insulin detemir/insulin aspart)
Number of subjects: 72
Study 28099755 — intervention group
Group type: COMPARATOR
Intervention: Human insulin (human NPH insulin/human regular insulin)
Number of subjects: 72
Study 25956891 — intervention group
Group type: EXPERIMENTAL
Intervention: Valacyclovir (VACV) 2 g thrice daily for 90 days (n = 40)
Number of subjects: 87